07:00 , May 7, 2012 |  BC Week In Review  |  Company News

Aerocrine diagnostic news

The U.S. Bankruptcy Court for the Northern District of California awarded Aerocrine $1.3 million to resolve patent infringement claims against now-defunct Apieron Inc. Aerocrine had alleged that Apieron's Insight eNO system infringed Aerocrine's patents covering...
07:00 , May 24, 2010 |  BC Week In Review  |  Company News

Aerocrine, Apieron deal

Aerocrine acquired fellow diagnostic company Apieron's business and IP assets in a Chapter 7 bankruptcy auction for an undisclosed sum. As a result, Apieron's litigation against Aerocrine in the U.S. and Germany will be dismissed,...
07:00 , May 17, 2010 |  BC Week In Review  |  Company News

Aerocrine, Apieron diagnostic news

Aerocrine said the District Court of Mannheim, Germany, ruled that the company infringed the German version of a U.S. patent held by Apieron. However, since Apieron filed for bankruptcy in March in the U.S., the...
07:00 , Apr 12, 2010 |  BC Week In Review  |  Company News

Apieron diagnostic news

Apieron filed for Chapter 7 bankruptcy. As a result of the bankruptcy filing, patent infringement suits filed against Apieron by Aerocrine AB (SSE:AERO, Stockholm, Sweden) will be stayed. The suits alleged that Apieron's Insight eNO...
07:00 , Mar 24, 2008 |  BC Week In Review  |  Clinical News

Insight eNO regulatory update

Apieron received 510(k) clearance from FDA for its Insight eNO system to assess the amount of exhaled nitric oxide (eNO) in asthma patients' breath as a measure of airway inflammation, which can be used to...